Sterling Capital Management LLC Sells 14,107 Shares of Addus HomeCare Corporation $ADUS

Sterling Capital Management LLC lowered its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 97.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 366 shares of the company’s stock after selling 14,107 shares during the quarter. Sterling Capital Management LLC’s holdings in Addus HomeCare were worth $40,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of ADUS. NFJ Investment Group LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $29,000. Parallel Advisors LLC raised its stake in shares of Addus HomeCare by 66.3% in the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after acquiring an additional 161 shares during the period. State of Wyoming purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at approximately $79,000. Nisa Investment Advisors LLC raised its stake in shares of Addus HomeCare by 16.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after acquiring an additional 111 shares during the period. Finally, Persistent Asset Partners Ltd acquired a new position in shares of Addus HomeCare in the 2nd quarter worth approximately $98,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: TD Cowen raised its price target to $145 from $131 and kept a Buy rating, implying about 14% upside from $126.81. TD Cowen recommendations
• Positive Sentiment: Third-quarter EPS of $1.83 beat the $1.79 consensus and increased from $1.56 a year earlier. Revenue rose 7% to $387.7 million, slightly below estimates; the earnings growth and stronger adjusted EBITDA provide supportive operating context. Q3 results
• Positive Sentiment: Management expects the roughly $275 million AccentCare personal-care acquisition to close in Q1 2027 and projected a full-year adjusted EBITDA margin in the 13% range, offering a potential growth opportunity alongside its margin outlook. AccentCare timing and margin outlook
• Neutral Sentiment: Renewed discussion of Medicare for All could put home- and community-based care in focus, given Addus’ reliance on Medicaid-funded personal care. However, the policy is uncertain, and any reimbursement benefit would depend on legislation and payment rules. Healthcare stocks and Medicare for All
• Neutral Sentiment: A report says caregiver preferences for 40-hour workweeks are shaping Addus’ personal-care census strategy; the available details do not quantify the impact on staffing or growth. Caregiver scheduling strategy
• Negative Sentiment: Barclays raised its target to $101 from $96 but kept an Underweight rating, implying roughly 20% downside from $126.81—a notable counterpoint to TD Cowen’s bullish call. Barclays recommendations

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on ADUS shares. Barclays lifted their target price on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a report on Wednesday. Royal Bank Of Canada boosted their target price on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. TD Cowen upped their price target on Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research note on Thursday. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Finally, Truist Financial raised their price target on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research report on Thursday. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $134.70.

Addus HomeCare Stock Performance

NASDAQ ADUS opened at $126.81 on Friday. The company has a market cap of $2.37 billion, a P/E ratio of 21.14, a P/E/G ratio of 1.82 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.69. The stock has a 50-day moving average of $117.48 and a two-hundred day moving average of $106.80. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $131.59.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.04. The business had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.56 earnings per share. As a group, analysts anticipate that Addus HomeCare Corporation will post 6.33 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.